Dr. Adam Michael O'Toole, MD

Dr. O'Toole practices at Huntington Hospital - Unit in Pasadena, California.

Dr. O'Toole's NPI, 1467795575, was assigned on March 27, 2013. Dr. O'Toole graduated from Creighton University School of Medicine - Omaha in 2013. Dr. O'Toole holds California license A170617.

Dr. O'Toole's primary practice is Huntington Hospital - Unit, at 100 W. California Blvd, Pasadena, CA 91105 in Los Angeles County. The practice phone is (626) 397-2618.

Dr. O'Toole's primary practice is Huntington Hospital - Unit in Pasadena, California. Dr. O'Toole is also affiliated with Huntington Hospital. The medical group on file is Pasadena Cosmetic Surgery. Dmand AI also links Dr. O'Toole to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. O'Toole practices, 4 sites in all. Vendor and product names are available with a free account.

Plastic surgery is Dr. O'Toole's primary specialty in the NPI Registry, under taxonomy code 208200000X. Dr. O'Toole is board certified in plastic surgery by the American Board of Plastic Surgery. Dmand AI has Dr. O'Toole's licenses on file in 4 states: California, New Hampshire, Montana and Kentucky.

Dmand AI lists breast reconstruction and breast surgery among the conditions Dr. O'Toole treats.

CMS data shows 28 Medicare services from Dr. O'Toole across 2 procedure codes in 2024, for 55 Medicare patients. Medicare paid $2,299 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 55 Medicare patients who saw Dr. O'Toole in 2024. The largest group is 75 to 84, with 18 patients. 75% of them have high blood pressure, and 67% have high cholesterol. 36% are also on Medicaid. Their average risk score is 2.03, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. O'Toole's median patient age at 50, with 49% women.

In 2024, Dr. O'Toole wrote 95 Medicare Part D claims for 34 patients. 97% of them were for generic drugs. CMS names the drug for 63 of them, across 3 drugs with 11 or more claims each, at $312 in total drug cost. In 2023, CMS named 62 claims across 3 drugs.

Dr. O'Toole accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 3 papers to Dr. O'Toole in 2022. 2022 was the busiest year, with 3. Dr. O'Toole has published most often in Eplasty. Dr. O'Toole's most frequent co-authors are Joshua Hyosung Choo, MD, Milind Dilip Kachare, MD and Bradon J. Wilhelmi, MD.

CMS Open Payments shows 21 general payments to Dr. O'Toole from 11 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 79% of the total. Abbvie Inc. paid the most, $466.

Dr. O'Toole graduated from Creighton University School of Medicine - Omaha in 2013.

Dr. O'Toole is in network with 10 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 7. Check the plan with the practice before a visit.